Overview of Dr. Lipkin
Dr. Steven Lipkin is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital, New York-Presbyterian Hospital, and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of California San Diego School of Medicine and has been in practice 22 years. Dr. Lipkin accepts several types of health insurance, listed below. He is one of 378 doctors at New York-Presbyterian Hospital and one of 116 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. He has more than 100 publications and over 500 citings.
Office
1283 York Avenue
9th Floor
New York, NY 10065
Education & Training
- National Institutes of Health Clinical CenterResidency, Medical Genetics and Genomics, 1997 - 2000
- Duke University HospitalResidency, Internal Medicine, 1995 - 1998
- University of California San Diego School of MedicineClass of 1995
Certifications & Licensure
- CA State Medical License 2001 - Present
- NY State Medical License 2009 - 2026
- NC State Medical License 1998 - 2003
- American Board of Medical Genetics and Genomics Clinical Genetics and Genomics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Publications & Presentations
PubMed
- 6 citationsWhat happens in the long term: Uptake of cancer surveillance and prevention strategies among at-risk relatives with pathogenic variants detected via cascade testing.Melissa K Frey, Muhammad Danyal Ahsan, Nora Badiner, Jenny Lin, Priyanka Narayan
Cancer. 2022-12-15 - 46 citationsProspective Feasibility Trial of a Novel Strategy of Facilitated Cascade Genetic Testing Using Telephone Counseling.Melissa K. Frey, Ryan Kahn, Eloise Chapman-Davis, F. Tubito, Maira Pires
Journal of Clinical Oncology. 2020-01-10 - 36 citationsCascade Testing for Hereditary Cancer Syndromes: Should We Move Toward Direct Relative Contact? A Systematic Review and Meta-Analysis.Melissa K Frey, Muhammad Danyal Ahsan, Hannah Bergeron, Jenny Lin, Xuan Li
Journal of Clinical Oncology. 2022-12-10
Journal Articles
- Toward Automation of Germline Variant Curation in Clinical Cancer GeneticsSteven Lipkin, Karen Cadoo, Mark Robson, Kenneth Offit, Liying Zhang, Zsofia Stadler, Diana Mandelker, Nature
Press Mentions
- Health News | Researchers Find How Pathogenic Bacteria Trigger Crohn's DiseaseDecember 4th, 2022
- To Trigger Crohn’s Disease, Pathogenic Bacteria Co-Opt a Genetic SusceptibilityDecember 1st, 2022
- NIH Grant Funds Cancer Prevention Vaccine ResearchNovember 11th, 2022
- Join now to see all
Grant Support
- Mechanisms Of Host-Bacterial Interactions, Ileitis And Granuloma Formation In AGRNational Institute Of Diabetes And Digestive And Kidney Diseases2012
- Mechanisms Of Notch, NUMB And MET Signaling In Colon Cancer Initiating Cell AsymmNational Cancer Institute2011
- Mechanisms Of Notch Signalling In Colon Cancer Initiating CellsNational Cancer Institute2010–2011
- DNA Mismatch Repair And Associated Genes In Suppression Of GI Adenomas And CarcinNational Cancer Institute2010–2011
- UCI 07-70: Inhibiting EGF Receptor Signaling In Aberrant Crypt FOCI Of The ColonNational Center For Research Resources2010
- Phase IIA Trial Testing Erlotinib As An Intervention Against Intraductal PancreaNational Center For Research Resources2008–2010
- Mismatch Repair And Associated Genes In Suppression Of GI Adenomas And CarcinomasNational Cancer Institute2009
- Dasl-Crc: A Novel Approach To Identify Molecular Markers Of Metastatic RecurrenceNational Cancer Institute2009
- Dasl-Crc: A Novel Approach To Identify Molecular Markers Of Metastatic RecurrenceNational Cancer Institute2008
- Cancer Susceptibility And MSI Analyses Of MLH3 NULL MiceNational Cancer Institute2008
- Cancer Susceptibility And MSI Analyses Of MLH3 NULL MiceNational Cancer Institute2004–2008
- Hypomorphic Mismatch Repair Gene Mutations And Single Molecular MSI AnalysesNational Cancer Institute2006–2007
- Discovery Of Novel Genetic Variants Causing Colorectal *National Cancer Institute2004–2005
- Molecular Analyses Of MLH3 NULL MiceNational Cancer Institute2001–2003
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPOGreat West PPO
Health Net California Large Group PPO
MVP Healthcare PPO
Oxford Health Freedom
Oxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: